Current filters:  
Bereskin & Parr LLP
For many companies, a strong IP portfolio that covers key markets is their most valuable asset. Noel Courage and Don Bocchinfuso from Bereskin & Parr LLP, explain how different forms of IP...
Oyen Wiggs Green & Mutala
In previous Federal Court and Federal Court of Appeal proceedings concerning alleged infringement of four Bombardier patents...
Borden Ladner Gervais LLP
On June 29, 2020, the Federal Court issued its decision in the judicial review of recent Amendments1 to the Patented Medicines Regulations.
Norton Rose Fulbright Canada LLP
In view of the ongoing COVID-19 outbreak, on June 30 the Canadian Intellectual Property Office (CIPO)
Torys LLP
On June 29, the Federal Court released its much-awaited decision in a judicial review of the Governor in Council's decision to promulgate regulations amending the Patented Medicines Regulations.
Smart & Biggar
In view of the ongoing COVID-19 disruption, the Canadian Intellectual Property Office (CIPO) has further extended patent, trademark, and industrial design deadlines fixed under the relevant legislation.
Norton Rose Fulbright Canada LLP
Les nouveaux pouvoirs accordés aux examinateurs canadiens depuis la modification de la Loi sur les marques de commerce le 17 juin 2019 font mal aux demandeurs de marques de commerce.
Lenczner Slaght
The COVID-19 pandemic has required courts to adapt to new ways of providing access to justice. We have first-hand experience with this new reality.
Smart & Biggar
On June 29, 2020 the Federal Court released its decision in Innovative Medicines Canada et al. v The Attorney General of Canada et al, 2020 FC 725.
Intellectual property law has had an increasingly important place in international trade agreements and negotiations for many years.
Smart & Biggar
In view of the ongoing COVID-19 pandemic, the Canadian Intellectual Property Office (CIPO) has further extended patent, trademark, and industrial design
Smart & Biggar
Though there are many similarities between U.S. and Canadian patent law, the following significant differences can affect the key decision of whether to file in Canada.
Torys LLP
The coming-into-force of the amended Patented Medicines Regulations (Regulations), originally set for July 1, 2020, has now been delayed to January 1, 2021. Last week, ...
Norton Rose Fulbright Canada LLP
There appears to be no end to these extensions, and there remains a strong likelihood that CIPO will further extend deadlines in two weeks.
Blake, Cassels & Graydon LLP
On July 1, 2020, the Canada-United States-Mexico Agreement (CUSMA) and the Canada-United States-Mexico Agreement Implementation Act (Implementation Act) will come into force, replacing the North American Free Trade Agreement (NAFTA).
Goldman Sloan Nash & Haber LLP
For those who are interested in recent cases and developments about copyright and related matters, there have been several developments since the last entry.
Bereskin & Parr LLP
Trade secrets provide a business with an opportunity to obtain a commercial advantage over competitors who do not know or use the secret.
Borden Ladner Gervais LLP
A robust intellectual property (IP) strategy is crucial, particularly in the current business climate.
United States
The Court of Appeals for the Federal Circuit ruled in February that the Patent Trial and Appeal Board (PTAB) cannot cancel claims for indefiniteness in an inter partes review (IPR) proceeding.
Gowling WLG
Once you decide to file a patent, you must determine what it will cover. Obviously, you need to protect your invention, but to reduce the risk of others designing around your patent...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Upcoming Events
Font Size:
Mondaq Social Media